In our study, we reported a role for L‐2HG in promoting VM formation in RCC through a PHLDB2/MAPK pathway; however, the detailed mechanisms of PHLDB2 associated with RCC need further investigation. The gene discussed is PHLDB2; the disease is renal cell carcinoma.